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Conditional Activin Receptor Type 1B (Acvr1b)
Knockout Mice Reveal Hair Loss Abnormality
Wanglong Qiu1, Xiaojun Li1, Hongyan Tang2, Alicia S. Huang1, Andrey A. Panteleyev3, David M. Owens4,5
and Gloria H. Su1,5
The in vivo functions of the activin A receptor type 1b (Acvr1b) have been difficult to study because Acvr1b/
mice die during embryogenesis. To investigate the roles of Acvr1b in the epithelial tissues, we created mice with
a conditional disruption of Acvr1b (Acvr1bflox/flox) and crossed them with K14-Cre mice. Acvr1bflox/flox; K14-Cre
mice displayed various degrees of hairlessness at postnatal day 5, and the phenotype is exacerbated by age.
Histological analyses showed that those hair follicles that developed during morphogenesis were later
disrupted by delays in hair cycle reentry. Failure in cycling of the hair follicles and regrowth of the hair shaft and
the inner root sheath resulted in subsequent severe hair loss. Apart from previous reports of other members of
the transforming growth factor-b/activin/bone morphogenic protein pathways, we demonstrate a specialized
role for Acvr1b in hair cycling in addition to hair follicle development. Acvr1bflox/flox; K14-Cre mice also had a
thicker epidermis than did wild-type mice, which resulted from persistent proliferation of skin epithelial cells;
however, no tumor formation was observed by 18 months of age. Our analysis of this Acvr1b knockout
mouse line provides direct genetic evidence that Acvr1b signaling is required for both hair follicle development
and cycling.
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INTRODUCTION
The activin signaling transduction pathway has multiple roles
in mammalian development and tumorigenesis. Activins
were originally isolated as regulators of the follicle-stimulat-
ing hormone (Ling et al., 1986). Additional functions of
activins include roles in bone growth and bone morphogen-
esis (Merino et al., 1999), mesoderm induction, nerve cell
survival, wound healing, tissue differentiation, inflammation,
determination of left–right axes branching morphogenesis of
glandular organs (Smith et al., 1990; Thomsen et al., 1990;
Mathews et al., 1992; Hubner et al., 1997; Gu et al., 1998;
Woodruff, 1998; Song et al., 1999; Kim et al., 2000; Ball and
Risbridger, 2001; Chen et al., 2004; Thompson et al., 2004),
and tumor suppression (Matzuk et al., 1992; Su et al., 2001;
Burdette et al., 2005). Activins have also been described as
critical regulators of skin morphogenesis (Matzuk et al.,
1995b, c; Munz et al., 1999). Activins are dimers, comprising
two b-subunits linked by a single, covalent disulphide bond;
five different b-subunits (A–E) have been identified. Activins A
(bAbA) and B (bBbB) are the most common types expressed
in various tissues (McDowall et al., 2008).
Activin A receptor type 1b (Acvr1b), also termed ‘‘activin-
like kinase 4 (Alk4),’’ is a type I transmembrane serine/
threonine kinase receptor that is part of the transforming
growth factor-b (TGF-b) receptor superfamily (Massague,
1996, 1998; Piek et al., 1999). Activin binds to a type II
activin receptor (Acvr2 or Acvr2b) and then recruits Acvr1b
(Attisano et al., 1993). Receptor heterodimerization activates
the type II receptor kinase to phosphorylate the type I
receptor, which recruits and phosphorylates regulated
Smads2 and 3. Phosphorylated regulated Smads are released
and form a heteromeric complex with the Co-Smad, Smad4.
The regulated Smad and Co-Smad complex then translocates
to the nucleus where it regulates the expression of many
genes (Attisano et al., 1996; Heldin et al., 1997; Derynck
et al., 1998; Massague, 1996, 1998; Piek et al., 1999). In
mammals, Acvr1b is expressed by various types of epithelial
cells, including interfollicular epidermis, and the outer root
sheath (ORS) and the inner root sheath (IRS) of the
hair follicles (Roberts and Barth, 1994). Activin signaling
through Acvr1b acts on skin epithelial cells in a paracrine
manner. Other than activin, only nodal and myostatin
are known to signal through Acvr1b, and they are not
invoveld in hair growth (Yeo and Whitman, 2001; Zimmers
et al., 2002).
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The roles of activins and other TGF-b family members in
mammalian development have been extensively analyzed by
gene targeting studies in mice. Activin bA-deficient mice lack
whiskers, and incisor and mandibular molar teeth, and have
defective secondary palates, resulting in their death within
24 hours after birth because of impaired suckling (Matzuk
et al., 1995b; Ferguson et al., 1998). Mice deficient in activin
bB are viable, with normal mesoderm formation and
neurulation, but have defects in eyelid development and
female reproduction (Vassalli et al., 1994). Acvr2a
and Acvr2b are functionally redundant; hence, only a few
Acvr2a/ or Acvr2b/ mice have skeletal and facial
abnormalities; most lack these defects and develop into
adults (Matzuk et al., 1995a; Song et al., 1999). However,
Acvr2a/; Acvr2b/ (double mutant) mice fail to form the
primitive streak during embryogenesis, and Acvr2a/;
Acvr2bþ / mice have truncated brain development by
embryonic day 9.5 (Song et al., 1999). Activin receptor II
and activin bA mutants have similar defects in tooth
development (Ferguson et al., 2001). Acvr1b/ mice do
not survive beyond embryonic day 9.5 because of develop-
mental arrest of the egg cylinder before gastrulation
(Gu et al., 1998). To bypass the requirement of activin
signaling in embryonic development, transgenic mice that
overexpress activin A (Munz et al., 1999), the activin
inhibitor follistatin (Wang et al., 2004), or a dominant-
negative form of Acvr1b (Bamberger et al., 2005) were
generated and revealed additional roles for activin in skin
morphogenesis and/or wound healing.
In addition to the importance of activin signaling in
mammalian development (Verschueren et al., 1995; Gu
et al., 1998; Chen et al., 2004), Acvr1b can also function as a
tumor suppressor (Su et al., 2001; Danila et al., 2002). To
circumvent embryonic lethality and to explore the functions
of Acvr1b signaling in development and tumorigenesis, we
created mice with conditional disruption of Acvr1b using
Cre-loxP and Flp-FRT recombination technologies. To
investigate the roles of Acvr1b in the surface epithelial
tissues, we bred these mice with K14-Cre transgenic mice, to
generate Acvr1b flox/flox; K14-Cre mice.
RESULTS
Inactivation of Acvr1b in the surface epithelial tissues leads to
hair loss
In mice, Acvr1b consists of 9 exons, maps to chromosome 15
(60.4 cM), and encodes a 4.4-kb mRNA. We generated
conditional Acvr1b knockout mice using the Cre and Flp
recombinase systems (Supplementary Figure S1 online and
Figure 1). Acvr1b flox/flox mice appeared normal and fertile.
To investigate the role of Acvr1b in the epithelial tissues
such as the oral cavity, esophagus, and skin, we generated
Acvr1b flox/flox; K14-Cremice (Figure 1a–c). Epithelial-specific
genomic recombination of Acvr1b also occurred in the
tongue, esophagus, eye, forestomach, and thymus, but not in
the liver, stomach, lung, kidney, small bowel, large bowel,
heart, spleen, or brain of adult Acvr1b flox/flox; K14-Cre mice
(Figure 1d). This pattern of tissue-specific Acvr1b recombina-
tion was confirmed by reverse transcriptase-PCR (Figure 1e).
In the skin, Acvr1b expression and recombination were
restricted to the epidermis and not observed in the dermis
(Figure 1f). Acvr1b protein expression in the epidermis and
hair follicle epithelium of mutant mice was significantly
reduced as shown by immunohistochemical analysis with
anti-Acvr1b (Figure 1g). The reduced Acvr1b level was
sufficient to result in detectable downregulation of p-Smad2
expression (Figure 1h).
Newborn Acvr1bflox/flox; K14-Cre mice exhibited a wide
range of hair loss; B25% displayed visible hairlessness and
stunted growth at postnatal day 5 (P5), whereas 50% were
indistinguishable from wild-type mice (controls) (Figure 2).
However, as they aged, all Acvr1bflox/flox; K14-Cre mutant
mice exhibited increased hair loss (Figure 3, Supplementary
Figure S2 online). These phenotypes (diminutive size and
alopecia) were exacerbated in mice with two copies of K14-
Cre (Acvr1bflox/flox; K14-Cretg/tg) (Supplementary Figure S2b–d
online), indicating that the severity of the phenotypes was
associated with increased Cre activity and more efficient
deletion of Acvr1b in their hair follicles. All of the following
experiments were performed on mice with one copy of K14-
Cre. Our data indicate that downregulation of Acvr1b
expression has severe negative impacts on hair development.
Although keratin 14 expression has been reported in
mammary glands, Acvr1bflox/flox; K14-Cre adult female
mice were able to reproduce and nurse pups. Among
Acvr1bflox/flox; K14-Cre mutant mice, those with the severe
hair loss phenotype also had abnormalities in number, size,
and color of incisor teeth (Supplementary Figure S2 online).
Disruption of the hair follicle cycle in Acvr1b flox/flox; K14-Cre
mice
To investigate the hair loss observed in Acvr1bflox/flox; K14-
Cre mice in relation to the hair follicle cycle, we examined
the histology of the dorsal skin sample obtained from
Acvr1bflox/flox; K14-Cre mice at different developmental
stages, including follicular morphogenesis (P5), anagen
(P11), catagen (P17), telogen (P24), and anagen (P32) stages,
compared with littermate controls. As expected, those
Acvr1bflox/flox; K14-Cre mice with gross alopecia by P5
displayed corresponding abnormal hair follicles microscopi-
cally at morphogenesis (Figure 2c and f). Histological
analyses of the skin samples obtained from the least affected
Acvr1bflox/flox; K14-Cre mice showed only slight differences
from controls at P5, P11, and P17, but striking defects in hair
follicle morphology at later time points (at P24 and P32;
Figures 2b, e and 3). This result indicates that Acvr1b-
dependent signaling is essential for hair cycling in addition to
its involvement in hair development. At P5 and P11, the hair
follicles of these mutant mice were in an early and fully
developed anagen phase as controls, respectively; hair bulbs
had descended deep into the fat layer of the skin, and well-
differentiated hair shafts that had undergone terminal
differentiation and lacked nuclei were observed in control
and mutant mice (Figure 3a–d). At P17, the dorsal follicles of
control mice were in the catagen phase, whereas some of the
hair follicles in mutant mice were delayed in entering this
phase (Figure 3e and f). At P24, the follicles in control mice
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started to enter the anagen phase, from quiescence (telogen
phase), whereas the hair follicles of mutant mice stayed at
the regression (catagen) phase (Figure 3g and h). The skin of
Acvr1bflox/flox; K14-Cre mutant mice also started to exhibit
enlarged sebaceous glands. At P32, the skin follicles of
control mice were entering the full anagen phase; in contrast,
the follicles of mutant mice appeared to be completely
deregulated (Figure 3i and j). At P32, some mutant follicles
enter abnormal anagen, whereas the majority remains in
telogen (Supplementary Figure S3 online). Counting the hair
follicles at each stage of follicle growth revealed significant
differences between control and mutant mice, starting at day
22 (Supplementary Figure S3 online). These data indicated
that in mutant mice, the remnant hair follicles faced
detrimental cycling disruption starting at the first postnatal
hair cycle.
Epithelial Acvr1b signaling is required for the keratinized cortex
and IRS in hair differentiation
We then investigated whether the defective cycling pheno-
type observed in the hair follicles of mutant mice resulted
from abnormal follicle differentiation. In normal hair follicles,
AE13, which is an antibody against type I low-sulfur hair-
shaft cortex keratin (Lynch et al., 1986), stains the keratins of
the cortex and precortex of hair follicles. The cortex makes
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Figure 1. Genotyping and tissue-specific recombination in Acvr1b flox/flox; K14-Cre mice. (a) PCR strategies and primers (P) for Acrv1b genotyping and
Cre-mediated recombination. (b) Acvr1b genotyping using P1/P2 or P3/P4. The upper bands include a loxP site and are therefore bigger than the wild-type allele
(lower bands). (c) The recombined Acvr1b fragment was detected only in mice with the K14-Cre gene (using P4/P5). Tissue-specific recombination of Acvr1b
was detected at (d) the genomic DNA level and (e) confirmed by RT-PCR. (f) Acvr1b recombination was observed only in the epidermis (not the dermis) by
RT-PCR. (g) Acvr1b protein expression was dramatically decreased in the skin epidermis and hair follicle epithelia of an adult Acvr1b flox/flox; K14-Cre knockout
(KO) mouse compared with that of an adult wild-type (WT) mouse by anti-Acvr1b immunohistochemistry, which is supported by the downregulation of
p-Smad2 expression in epithelial cells of the mutant skin (P17) (arrows). P-Smad2 expression is maintained in fibroblast cells (triangle) in the mutant skin,
whereas non-specific expression is also observed in the sebaceous glands (*) (h). Acvr1b, activin A receptor type 1b; RT-PCR, reverse transcriptase-PCR. All scale
bars¼ 50 mm.
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recognizes proteins in the medulla of the hair shaft and in the
IRS (O’Guin et al., 1992), stains all three layers of the IRS and
medulla of the hair follicles (Figure 4a and c, Supplementary
Figures S4a, c, and e, and S5a, c, and e online). In
Acvr1bflox/flox; K14-Cre mice, AE13 staining was reduced as
the hair follicles became disorganized (Supplementary Figure
S4b, d, and f online) and was absent from most follicles by the
anagen phase (P32; Figure 4b). With AE15, normal staining
patterns were observed during morphogenesis, but were
visibly reduced as the hair cycle became deregulated (Figure
4d, Supplementary Figure S5b, d, and f online). These
findings indicate the absence of the keratinized cortex and
defective differentiation of the IRS and hair-shaft medulla in
these follicles (Figure 4b and d). They also indicated that
matrix cells failed to differentiate toward the IRS and hair
shaft in the follicles of mutant mice in preparation for hair
cycle reentry. These events might have contributed to the
subsequent failure in hair cycling and demonstrate a role for
Acvr1b signaling in hair differentiation.
Keratin 5 proteins are specifically expressed in the
epidermal basal layer and ORS of the normal hair follicle
(Figure 4e) (Byrne et al., 1994). Keratin 6 proteins are specific
for the companion cell layer that separates the ORS from the
IRS (Figure 4g) (Wang et al., 2003). High expression levels of
keratin 5 and keratin 6 markers were maintained in the hair
follicles of Acvr1bflox/flox; K14-Cre mice (Figure 4f and h and
Supplementary Figure S6 online). This observation demon-
strates that differentiation of the epidermal basal layer, ORS,
and companion cell layer was unaffected by deletion of
Acvr1b.
To further investigate aberrations in hair differentiation,
using immunohistochemistry, we examined the expression of
the transcription factor Lef1, which regulates hair-specific
keratin genes (Zhou et al., 1995). Surprisingly, although
follicles of Acvr1bflox/flox; K14-Cre mice lost immunoreactiv-
ity with AE13 as they became deregulated, Acvr1b-null
follicles had increased numbers of Lef1-positive cells
per hair follicle (Supplementary Figure S7 online). At the
catagen phase (P17), increased levels of Lef1 expression
were observed in the matrix cells of mutant hair follicles
(Figure 4j), compared with littermate controls (Figure 4i).
Increased proliferation in the epidermis and follicles of aging
Acvr1bflox/flox; K14-Cre mice
A total of 20 Acvr1bflox/flox; K14-Cre mice were observed for
18 months to examine the long-term effects of Acvr1b
deletion in the skin epidermis. The severity of the hair loss
phenotype increased with aging. At 5 months, Acvr1bflox/flox;
K14-Cre mice were completely alopecic. The few remaining
hair follicles were abnormally enlarged, without shaft
formation (Figure 5b–f); the defective, dilated hair follicles
resulted in large cysts that contained keratinaceous debris
(Figure 5c, e, and f). These mice also had increased size and
numbers of sebaceous glands in their skin (Figure 5d).
Increased proliferation was also observed in the few
remaining hair follicles of mutant mice (Figure 5g and i).
BrdU-positive cells could be observed in the upper ORS of
the remaining hair follicles with or without cyst association
(Figure 5i). The percentage of BrdU-positive cells per hair
follicle in Acvr1bflox/flox; K14-Cre mice (11.2±3.5%) was
Figure 2. Distinct severity of hair loss displayed among Acvr1bflox/flox; K14-Cre conditional knockout mice. Three 10-day-old mice of (a) the wild-type
genotype or the (b, c) Acvr1bflox/flox; K14-Cre genotype. Acvr1bflox/flox; K14-Cre mutant mice displayed a gradient of abnormal hair morphogenesis. Here, we
show representatives of mutant mice with relative unaffected hair development (panel b) or grossly hairless phenotype (panel c). The corresponding histological
H&E sections for (d) wild-type and (e, f) two mutant mice are also shown here. Histology analyses are consistent with the gross hair phenotypes. Acvr1b, activin
A receptor type 1b; H&E, hematoxylin and eosin. All scale bars¼50 mm.
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significantly greater than that in controls (6.2±3.6%)
(Po0.01). Those hair follicles that had completely disinte-
grated into cysts did not display increased BrdU positivity.
By 5 months of age, the epidermis of Acvr1bflox/flox; K14-
Cre mice was also thicker than that of controls (Figure 5). The








Figure 3. Histological analyses of postnatal hair follicle development in
Acvr1b flox/flox; K14-Cre mice. Hematoxylin–eosin staining analysis of tissue
sections from the control (a, c, e, g, i) and mutant (b, d, f, h, j) dorsal skin at P5
(panels a and b), P11 (panels c and d), P17 (panels e and f), P24 (panels g and
h), and P32 (panels i and j). Hair follicle development was similar between
control and mutant mice at P5 and P11. The skin of control mice at P17 (panel
e) was at the catagen phase, whereas follicles of the matched mutant mice
(panel f) were at a mixed anagen and catagen phase. The skin of control mice
at P24 (panel g) was in transition from the telogen to the anagen phases,
whereas the mutant follicles were mostly at the catagen phase (panel h). At
P32, the follicles of control mice were entering the full anagen phase (panel i),
whereas mutant mice remained at the catagen and telogen phases (panel j).











Figure 4. Defects in hair shaft and IRS differentiation in conditional
Acvr1b flox/flox; K14-Cre mutant mice. The antibody AE13 stains the precortex
and cortex of the hair keratin in (a) wild-type mice, whereas (c) AE15 stains
the IRS and medulla of hair follicles. (b) AE13 and (d) AE15 staining were
significantly reduced in Acvr1b flox/flox; K14-Cre mutant mice at anagen (P32).
Sebaceous gland cells were non-specifically stained. (e–h) K5 and K6 markers
appeared to be maintained in the follicles of mutant mice (panels f and h)
compared with wild-type littermates at anagen (P11) (panels e and g). Higher
levels of (i, j) Lef1 expression were observed in the matrix cells of the hair
follicles of mutant mice at catagen (p17). Acvr1b, activin A receptor type 1b;
IRS, inner root sheath. All scale bars¼ 50 mm.
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and i) had 3–5 more basal layers of epithelial cells than did
littermate controls (Figure 5a and g). BrdU incorporation was
10-fold greater in the basal layer of the epidermis of mutant
mice (22.9±13.6) (Figure 5h and i) than in that of controls
(2.5±1.5; Po0.0001) (Figure 5g).
No differences in epidermal proliferation were apparent
between Acvr1bflox/flox; K14-Cre mice and controls at young
ages (from P11 to P32; Figure 3a–h). The numbers of BrdU-
positive cells per hair follicle were also not significantly
higher in mutants than in controls before P32 (Supplementary
Figure S8 online). The persistent proliferation of epidermal
and follicular epithelial cells only becomes apparent as mice
age, possibly resulting from accumulative deregulation of
activin signaling over time.
Samples collected from the skin, tongue, and esophagus
of mice were also examined at 5-, 6-, 8-, 10-, 12-, 15, and
18-month time points in Acvr1bflox/flox; K14-Cre mice and
controls. No gross anatomical difference and no tumor







Figure 5. Histological analyses of the dorsal skin in adult wild-type and conditional Acvr1b flox/flox; K14-Cre mice. (a) The dorsal skin of 5-month-old wild-type
mice was stained with hematoxylin–eosin or (g) with anti-BrdU after incorporation (g). The dorsal skin of 5-month-old mutant mice was stained with (b–f)
hematoxylin–eosin or (h, i) with anti-BrdU after incorporation. Increased hyperplasia (arrows) and cell proliferation (arrowheads) were observed in the epidermis
as hair loss and disintegration of the hair follicles (asterisk) became more apparent in aging mutant mice. Acvr1b, activin A receptor type 1b. All scale
bars¼ 50 mm.
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DISCUSSION
The Acvr1bflox/flox; K14-Cre mutant mice displayed a high
level of Acvr1b recombination in the skin and tongue and a
low level in the esophagus and forestomach (Figure 1d and
e). These results are consistent with previous studies that
showed that K14-Cre mice had high levels of Cre activity in
the epidermis, hair follicles, oral epithelium, and developing
teeth and low levels in the esophagus and forestomach at
embryonic day 14.5 and P1 (Vassar and Fuchs, 1991; Byrne
et al., 1994; Wang et al., 1997). Despite the frequent
recombination events observed in the tongue and skin,
the most prominent phenotypes of Acvr1bflox/flox; K14-cre
mice were observed in the skin. The skin might require
greater levels of Acvr1b-dependent activin signaling than the
tongue, or the high level of K14 expression in the skin might
cause more severe phenotypes. The abnormalities observed
in Acvr1bflox/flox; K14-cre mice are presumably due to the
lack of Acv1b-dependent signaling through Smad2, because
p-Smad2 expression was absent in response to the loss of
Acv1b expression (Figure 1).
The severity of the hair loss phenotype observed in
Acvr1bflox/flox; K14-Cre mice depended on the efficiency of
Cre-recombination and increased with age (Figure 2, Supple-
mentary Figure S2, 3, and 5 online). Mutant mice also had
abnormal tooth morphogenesis (missing, shortening, or
overextending incisors) (Supplementary Figure S2 online).
These phenotypes are distinct from those observed in activin
bA-deficient mice, which lacked vibrissae, vibrissae follicles,
incisor, and mandibular molar teeth; these mice died within
24 hours of birth (Matzuk et al., 1995b; Ferguson et al.,
1998). The differences in phenotypes might arise because
activin signaling has many roles in embryonic development
and in Acvr1bflox/flox; K14-Cre mice, Acvr1b is inactivated
later in development (Matzuk et al., 1995a; Gu et al., 1998;
Song et al., 1999). The differences are not likely to arise
from inefficient Cre recombination in the oral cavity
because transgenic mice that express a dominant-negative
form of Acvr1b have mild delays in postnatal hair follicle
morphogenesis, but not incisor abnormality or shorten
lifespan (Bamberger et al., 2005). A closer examination of
Acvr1bflox/flox; K14-Cre revealed an important role for Acvr1b
in both hair follicle development and hair cycle reentry.
Disruption in the re-development of the IRS and hair shaft
during hair regrowth might have contributed to the defective
hair cycling reentry and continual hair loss beyond morpho-
genesis. Our studies of Acvr1bflox/flox; K14-Cre mice reveal a
previously unreported role for activin signaling in hair cycling
and incisor phenotypes.
Other studies in which TGF-b/bone morphogenic protein
family members were inhibited demonstrated their involve-
ment in hair follicle morphogenesis. Mice deficient in
TGF-b2, Bmpr1a, noggin, Smad4, or Smad7 have a profound
delay in hair follicle development and differentiation
(Botchkarev et al., 1999; Foitzik et al., 1999; Kobielak
et al., 2003; Han et al., 2006; Qiao et al., 2006; Owens et al.,
2008). Acvr1b signaling differs from that of other TGF-b
receptors in that it has an additional role in hair follicle
cycling. Lef1 expression was lost in Smad4flox/flox; MMTV-Cre
mice, whereas overexpression of Left1 was observed in
Bmpr1aflox/flox; K14-Cre and Acvr1bflox/flox; K14-Cre mice
(Figure 4, Supplementary Figure S6 online) (Kobielak et al.,
2003; Qiao et al., 2006). Our data, together with previous
studies, indicate that although the ligands, receptors, and
mediators of the TGF-b, activin, bone morphogenic protein
signaling pathways all contribute to hair follicle development
and differentiation, yet each has non-overlapping function
that cannot be compensated by the expressions of the others,
because the absence of one gene would significantly impact
the normalcy of hair follicles.
Hair follicle morphogenesis and hair cycling are con-
trolled by complex, bidirectional epithelial–mesenchymal
interactions (Fuchs and Raghavan, 2002; Millar, 2002). We
show that Acvr1b is expressed in epithelial compartments,
but not in dermal cells, which are consistent with previous
studies (Nakamura et al., 2003). Activin was mainly
expressed in the mesenchyme. Therefore, it was proposed
that activin-bA, produced by cells of the mesenchymal
compartment, binds to activin receptors in the epithelial
compartment of the hair follicle to inhibit hair follicle
development (Nakamura et al., 2003). Hair follicular
morphogenesis initiates from an epithelial downgrowth,
which proliferates and differentiates to first form the IRS
and then the hair shaft itself. In this study, we show that
Acvr1b signaling is required for the differentiation and
regrowth of IRS and hair shaft in adult mice (Figure 4,
Supplementary Figures S4 and S5 online). It remains
unknown whether the defective IRS and hair shaft result
directly from Acvr1b loss or from a lack of proper progenitor
cells that give rise to these structures. Further studies are
required to determine whether Acvr1b signaling requirements
in the IRS and hair-shaft development differ between the
embryonic and the first postnatal anagen phase. It is possible
that the secondary hair germ cells and bulge stem cells are
directly affected by Acvr1b inactivation and that damage to
these cells reduces the progenitor population required for
anagen-phase hair follicle regrowth (Ito et al., 2004). The
lower-most portion of the telogen follicle consists of the bulge
and secondary hair germ, and the progeny of stem cells in the
bulge form the lower follicle and hair (Wilson et al., 1994). In
Acvr1bflox/flox; K14-Cremice, secondary hair germ cells might
not be able to survive an extended, aberrant catagen phase,
and bulge stem cells might also become impaired. Fibroblast
growth factor, activin/bone morphogenic protein, and Wnt
signaling have been implicated in regulating hair germ cell
and bulge cells in hair regeneration (Wilson et al., 1994;
Ohyama et al., 2006). It will be important to examine the
role of Acvr1b in regulating hair germ and bulge
stem cells.
Although Acvr1bflox/flox; K14-Cre mice had abnormal
incisors, the mechanisms of this phenotype are unknown.
The chalky white color of the incisors indicates severe
enamel defects in Acvr1bflox/flox; K14-Cre mice. The normal
maintenance of the sharp, cutting edge of the continuously
growing rodent incisor depends on the asymmetric deposi-
tion of enamel, and the physical contacts of the upper and
lower incisors keep each other sharp and to prevent
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overgrowth. Therefore, overextending incisors observed in
mutant mice also suggest enamel problems and/or compro-
mised growth of the incisor epithelium. The epithelial stem
cell niche is located at the apical end of the tooth, and its
progeny give rise to ameloblasts that form the hard enamel
(Jernvall and Thesleff, 2000; Thesleff et al., 2001). Recent
studies have shown that activin A regulates the proliferation
of incisor epithelial stem/progenitor cells (Thesleff et al.,
2007; Wang et al., 2007). Our data suggest a possible role of
Acvr1b in regulating enamel development and will be further
investigated in future studies.
Activin inhibits growth in many types of cells and acts as a
tumor suppressor in tumorigenesis. Activins have been shown
to have tumor-suppressive properties in endocrine, breast,
liver, kidney, and brain cells (Risbridger et al., 2001; Su et al.,
2001; Danila et al., 2002; Burdette et al., 2005; Panopoulou
et al., 2005). Somatic mutations of activin receptors,
including ACVR1B, have been reported in many tumor types
(D’Abronzo et al., 1999; Su et al., 2001; Hempen et al.,
2003; Rossi et al., 2005). In most tissues, activins therefore
inhibit the development of cancer. In this study, disruption of
Avcr1b-dependent activin signaling resulted in hyperplasia of
the epidermis and in persistent proliferation of skin epithelial
cells at 5 months of age (Figure 5). These data support a
tumor-suppressive role of Acvr1b, consistent with previous
data that indicate that activin signaling mediates proliferation
and differentiation of skin epithelial cells (Matzuk et al.,
1995c; Munz et al., 1999; Cruise et al., 2004). However,
unlike the spontaneous tumor formation observed in Smad4,
Bmpr1a, and TbetaRII conditional knockout mice (Kobielak
et al., 2003; Qiao et al., 2006), conditional deletion of Acvr1b
was not sufficient to initiate tumor formation in the skin.
Our study of the first conditional Acvr1b knockout mouse
line provides direct evidence that Acvr1b signaling has a
required and a specific role in the cycling and differentiation
of hair follicle and tooth morphogenesis. The mechanisms
behind these phenotypes remain to be elucidated. Similar to
those mice with condition disruptions in activin bA, Smad, or
Bmpr1a, loss of Acvr1b affected hair follicle morphogenesis.
However, our data also reveal an additional role for Acvr1b
in hair follicle cycling and the differentiation of IRS and hair
shaft, indicating that TGF-b receptor family, its ligands, and
mediators each has a specific role in hair follicle develop-
ment, differentiation, and cycling. As Acvr1b/ mice die
during embryogenesis, mice with conditional disruption of




To our knowledge, a previously unreported conditional Acvr1b
knockout mouse model was generated with Cre and Flp recombi-
nase systems. In brief, Cre-induced recombination would delete
exons 2 and 3 of the Acvr1b gene and result in a frameshift mutation
that eliminates Acvr1b expression. Details on the generation of the
targeting construct, selection of embryonic stem cell clones,
generation of chimeric mice, and germline transmission are as
described in Supplementary Data online (‘‘Materials and Methods’’
and Supplementary Figure S1 online). CMV-Flp transgenic mouse
was a gift from Dr Thomas Ludwig at the Columbia University
Medical Center. K14-Cre transgenic mouse (FVB-Tg(K14-Cre)8Brn)
was obtained from the Mouse Repository of the Mouse Models of
Human Cancers Consortium (Jonkers et al., 2001). All mouse lines,
including Acvr1b-floxed mice, were maintained by backcrossing to
C57BL/6J.
DNA and RNA isolations and analyses
The Acvr1b-floxed mice were genotyped by detection of the loxP
loci, and Cre-mediated recombination was determined by PCR and
reverse transcriptase-PCR strategies that used genomic DNA or RNA,
respectively (Figure 1 and Supplementary Data online). In brief, the
PCR strategy is as depicted in Figure 1a. The primers for reverse
transcriptase-PCR are located within exons 1 and 5, flanking exons 2
and 3 of the Acvr1b cDNA sequences.
Histology
Tissue samples were fixed in 10% formalin (containing 4%
paraformaldehyde), embedded in paraffin, and cut into 5-mm
sections. Frozen tissues were embedded in optimal cutting
temperature compound and stored at 80 1C. The samples that
contained bone were decalcified with 4% formic acid and 4%
hydrochloric acid for 4 hours after fixation. For histological analysis,
sections were stained with hematoxylin and eosin. Detailed
protocols on immunohistochemistry are listed in the ‘‘Materials
and Methods’’ section in Supplementary Data online.
Detection of proliferating cells by labeling with BrdU
Mice were administered intraperitoneal injections of BrdU (100mg
BrdU per 1 kg body weight, Sigma-Aldrich, St Louis, MO) and killed
2 hours after injection. Skin samples from wild-type and mutant mice
were fixed in 10% formalin overnight and embedded in paraffin.
Deparaffinized 5-mm sections were rehydrated, and subjected to the
detection of BrdU incorporation with biotinylated mouse anti-BrdU
(Zymed Laboratories/Invitrogen, Carlsbad, CA). The detailed proce-
dure was performed according to the recommendations of the
manufacturer.
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